16 Oct 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Becton Dickinson (BD) Medical launched the BD Vystra Disposable Pen at the 2012 Parenteral Drug Association Meeting in Las Vegas. This new self-injection pen has been designed for use with a wide range of therapies that require frequent, low-volume injections or variable dosing.
BD Vystra Disposable Pen has been optimized for ease-of-use, comfort and reliability through rigorous ergonomic and quality assessments to ensure an intuitive, confident user experience. Design features of this pen injector include multi-dosing, simple dose dialing and correction with audible clicks, and large and clear dose markings.
Dr Krista Thompson, VP and global leader, pharmaceutical systems, self-administration injection systems platform, BD Medical, said that, "As more patient care shifts to the out-patient setting, self-injection devices must be able to accommodate the requirements of an ever broader range of drugs and patient profiles."
"With the BD Vystra Disposable Pen, BD has incorporated several customization options to meet these needs, such as variable or fixed dosing and multiple look-and-feel designs. This ability to customize the device introduces a new level of flexibility for drug manufacturers," added Dr Thompson.
With BD's 115-year heritage and extensive drug delivery experience, the company is also able to offer pharmaceutical customers full-service support with worldwide reach ranging from pre-clinical to commercialization, along with the reassurance of strong IP protection.